Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:2204-2211

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kojima, M.
Right arrow Articles by Kadowaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kojima, M.
Right arrow Articles by Kadowaki, T.

Circulation, Vol 89, 2204-2211, Copyright © 1994 by American Heart Association


ARTICLES

Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro

M Kojima, I Shiojima, T Yamazaki, I Komuro, Z Zou, Y Wang, T Mizuno, K Ueki, K Tobe and T Kadowaki
Department of Medicine III, Tokyo University School of Medicine, Japan.

BACKGROUND: Previous studies have demonstrated that angiotensin II (Ang II) acts as a growth-promoting factor directly on cardiac myocytes and that angiotensin-converting enzyme inhibitor induces regression of hypertrophied hearts both in experimental animals and in humans. These results suggest that the renin-angiotensin system (RAS) is involved in the formation of left ventricular hypertrophy (LVH). To elucidate the role of RAS in the progression of cardiac hypertrophy, we evaluated the effect of an Ang II receptor antagonist on LVH in spontaneously hypertensive rats (SHRs) and investigated the molecular mechanisms by which antagonizing Ang II receptors reduces cell hypertrophy of myocytes using the in vitro model of mechanical stretch. METHODS AND RESULTS: In the in vivo study, we treated SHRs with the nonpeptide Ang II receptor antagonist TCV-116 (0.1, 1, or 10 mg/kg per day) or hydralazine (10 mg/kg per day). Blood pressure was measured by the tail- cuff method, and wall thickness of left ventricle was serially monitored using M-mode echocardiography. Rats were killed at the age of 13, 17, 21, or 25 weeks, and left ventricular (LV) weight, transverse diameter of cardiomyocytes, relative amount of V3 myosin heavy chain (MHC), and degree of interstitial collagen accumulation were examined. Untreated SHRs progressively developed severe hypertension, but treatment with TCV-116 or hydralazine inhibited the increase in blood pressure. Treatment with TCV-116 reduced LV weight, LV wall thickness, transverse diameter of myocytes, relative amount of V3 MHC, and interstitial fibrosis, whereas treatment with hydralazine slightly prevented an increase in LV wall thickness but did not exert significant reduction in other parameters. In the in vitro study, neonatal rat cardiomyocytes were cultured on deformable silicone dishes and mechanically stretched with or without pretreatment of CV-11974 (an active metabolite of TCV-116), and [3H]phenylalanine incorporation, activity of mitogen-activated protein (MAP) kinase, and c-fos mRNA expression were analyzed. Pretreatment of cultured cardiomyocytes with 10(-7) mol/L CV-11974 inhibited an increase in [3H]phenylalanine incorporation, MAP kinase activity, and c-fos gene expression induced by stretch of cardiomyocytes. CONCLUSIONS: The Ang II receptor antagonist TCV-116 induced regression of cardiac hypertrophy and had cardioprotective effects on hypertrophied myocardium in vivo, and antagonizing Ang II receptors inhibited intracellular signaling of stretch-mediated cardiomyocyte hypertrophy in vitro. These results suggest a crucial role of the cardiac RAS in the development of LVH produced by pressure overload.


This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al.
Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy
Circ. Res., December 8, 2006; 99(12): 1411 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Gupta, D. Young, and S. Sen
Inhibition of NF-{kappa}B induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H20 - H29.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Rosenkranz
TGF-{beta}1 and angiotensin networking in cardiac remodeling
Cardiovasc Res, August 15, 2004; 63(3): 423 - 432.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Yasunari, K. Maeda, T. Watanabe, M. Nakamura, J. Yoshikawa, and A. Asada
Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2116 - 2123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Niu, T. Shindo, H. Iwata, S. Iimuro, N. Takeda, Y. Zhang, A. Ebihara, Y. Suematsu, K. Kangawa, Y. Hirata, et al.
Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage
Circulation, April 13, 2004; 109(14): 1789 - 1794.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Otsuka, H Takahashi, M Shiratori, H Chiba, and S Abe
Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist
Thorax, January 1, 2004; 59(1): 31 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Sato, H. Yaoita, K. Maehara, and Y. Maruyama
Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H359 - H368.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Shiojima, M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, J. Tao, A. Rosenzweig, C. R. Kahn, E. D. Abel, and K. Walsh
Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status
J. Biol. Chem., September 27, 2002; 277(40): 37670 - 37677.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Nagata, F. Somura, K. Obata, M. Odashima, H. Izawa, S. Ichihara, T. Nagasaka, M. Iwase, Y. Yamada, N. Nakashima, et al.
AT1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats
Hypertension, August 1, 2002; 40(2): 168 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Kobayashi, S. Nakano, S.-i. Mita, T. Kobayashi, T. Honda, Y. Tsubokou, and H. Matsuoka
Involvement of Rho-Kinase Pathway for Angiotensin II-Induced Plasminogen Activator Inhibitor-1 Gene Expression and Cardiovascular Remodeling in Hypertensive Rats
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Iemitsu, T. Miyauchi, S. Maeda, S. Sakai, T. Kobayashi, N. Fujii, H. Miyazaki, M. Matsuda, and I. Yamaguchi
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2029 - R2036.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Kamogawa, S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei
Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo
Cardiovasc Res, June 1, 2001; 50(3): 509 - 515.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Tamura, S. Said, J. Harris, W. Lu, and A. M. Gerdes
Reverse Remodeling of Cardiac Myocyte Hypertrophy in Hypertension and Failure by Targeting of the Renin-Angiotensin System
Circulation, July 11, 2000; 102(2): 253 - 259.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. G Brilla
Renin-angiotensin-aldosterone system and myocardial fibrosis
Cardiovasc Res, July 1, 2000; 47(1): 1 - 3.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Ruwhof and A. van der Laarse
Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways
Cardiovasc Res, July 1, 2000; 47(1): 23 - 37.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. G Brilla
Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs
Cardiovasc Res, May 1, 2000; 46(2): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. G Stanley, H. Patel, A. L Knight, and B. Williams
Mechanical strain-induced human vascular matrix synthesis: The role of angiotensin II
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 32 - 35.
[Abstract] [PDF]


Home page
CirculationHome page
M. Shimoyama, D. Hayashi, E. Takimoto, Y. Zou, T. Oka, H. Uozumi, S. Kudoh, F. Shibasaki, Y. Yazaki, R. Nagai, et al.
Calcineurin Plays a Critical Role in Pressure Overload-Induced Cardiac Hypertrophy
Circulation, December 14, 1999; 100(24): 2449 - 2454.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata
Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats
Cardiovasc Res, December 1, 1999; 44(3): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Kim, T. Lee, J. Fu, and M. E. Ritchie
Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1808 - H1816.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Dostal and K. M. Baker
The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function?
Circ. Res., October 1, 1999; 85(7): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Jalili, Y. Takeishi, and R. A Walsh
Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC {beta}I, and PKC
Cardiovasc Res, October 1, 1999; 44(1): 5 - 9.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Brunner
Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat
Cardiovasc Res, October 1, 1999; 44(1): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. C Wollert and H. Drexler
The renin-angiotensin system and experimental heart failure
Cardiovasc Res, September 1, 1999; 43(4): 838 - 849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamamoto, Q. N. Dang, S. P. Kennedy, R. Osathanondh, R. A. Kelly, and R. T. Lee
Induction of Tenascin-C in Cardiac Myocytes by Mechanical Deformation. ROLE OF REACTIVE OXYGEN SPECIES
J. Biol. Chem., July 30, 1999; 274(31): 21840 - 21846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Ogino, B. Cai, A. Gu, T. Kohmoto, N. Yamamoto, and D. Burkhoff
Factors contributing to pressure overload-induced immediate early gene expression in adult rat hearts in vivo
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H380 - H387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Tanimura, V. G. Sharov, H. Shimoyama, T. Mishima, T. B. Levine, S. Goldstein, and H. N. Sabbah
Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1385 - H1392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Fujii, S. Umemoto, A. Fujii, T. Yonezawa, T. Sakumura, and M. Matsuzaki
Angiotensin II Type 1 Receptor Antagonist Downregulates Nonmuscle Myosin Heavy Chains in Spontaneously Hypertensive Rat Aorta
Hypertension, April 1, 1999; 33(4): 975 - 980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Thurmann, P. Kenedi, A. Schmidt, S. Harder, and N. Rietbrock
Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension
Circulation, November 10, 1998; 98(19): 2037 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. E. Cingolani, B. V. Alvarez, I. L. Ennis, and M. C. Camilion de Hurtado
Stretch-Induced Alkalinization of Feline Papillary Muscle : An Autocrine-Paracrine System
Circ. Res., October 19, 1998; 83(8): 775 - 780.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yano, S. Kim, Y. Izumi, S. Yamanaka, and H. Iwao
Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension
Circ. Res., October 5, 1998; 83(7): 752 - 760.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Hu, P. Gaudron, H.-J. Anders, F. Weidemann, O. Turschner, M. Nahrendorf, and G. Ertl
Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin
Cardiovasc Res, August 1, 1998; 39(2): 401 - 412.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Mazzolai, J. Nussberger, J.-F. Aubert, D. B. Brunner, G. Gabbiani, H. R. Brunner, and T. Pedrazzini
Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System
Hypertension, June 1, 1998; 31(6): 1324 - 1330.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Harada, I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, et al.
Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice
Circulation, May 19, 1998; 97(19): 1952 - 1959.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamamoto, Q. N. Dang, R. A. Kelly, and R. T. Lee
Mechanical Strain Suppresses Inducible Nitric-oxide Synthase in Cardiac Myocytes
J. Biol. Chem., May 8, 1998; 273(19): 11862 - 11866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Sakata, B. D. Hoit, S. B. Liggett, R. A. Walsh, and G. W. Dorn II
Decompensation of Pressure-Overload Hypertrophy in G{alpha}q-Overexpressing Mice
Circulation, April 21, 1998; 97(15): 1488 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Yamazaki, I. Komuro, S. Kudoh, Y. Zou, R. Nagai, R. Aikawa, H. Uozumi, and Y. Yazaki
Role of Ion Channels and Exchangers in Mechanical Stretch–Induced Cardiomyocyte Hypertrophy
Circ. Res., March 9, 1998; 82(4): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Zou, I. Komuro, T. Yamazaki, S. Kudoh, R. Aikawa, W. Zhu, I. Shiojima, Y. Hiroi, K. Tobe, T. Kadowaki, et al.
Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways : Critical Roles of Gß{gamma} Subunit, Src Family, and Ras in Cardiac Fibroblasts
Circ. Res., February 23, 1998; 82(3): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. A.A. van Heugten, M. C. van Setten, K. Eizema, P. D. Verdouw, and J. M.J. Lamers
Sarcoplasmic reticulum Ca2+ ATPase promoter activity during endothelin-1 induced hypertrophy of cultured rat cardiomyocytes
Cardiovasc Res, February 1, 1998; 37(2): 503 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Wharton, K. Morgan, R. A. D. Rutherford, J. D. Catravas, A. Chester, B. F. Whitehead, M. R. D. Leval, M. H. Yacoub, and J. M. Polak
Differential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human Heart
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 323 - 336.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Yamazaki, I. Komuro, Y. Zou, S. Kudoh, I. Shiojima, T. Mizuno, Y. Hiroi, R. Nagai, and Y. Yazaki
Efficient Inhibition of the Development of Cardiac Remodeling by a Long-Acting Calcium Antagonist Amlodipine
Hypertension, January 1, 1998; 31(1): 32 - 38.
[Abstract] [Full Text]


Home page
HypertensionHome page
Y. Izumi, S. Kim, T. Murakami, S. Yamanaka, and H. Iwao
Cardiac Mitogen-Activated Protein Kinase Activities Are Chronically Increased in Stroke-Prone Hypertensive Rats
Hypertension, January 1, 1998; 31(1): 50 - 56.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Magga, O. Vuolteenaho, M. Marttila, and H. Ruskoaho
Endothelin-1 Is Involved in Stretch-Induced Early Activation of B-Type Natriuretic Peptide Gene Expression in Atrial but Not in Ventricular Myocytes : Acute Effects of Mixed ETA/ETB and AT1 Receptor Antagonists In Vivo and In Vitro
Circulation, November 4, 1997; 96(9): 3053 - 3062.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Segar, T. D. Scholz, K. A. Bedell, O. M. Smith, D. J. Huss, and E. N. Guillery
Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1501 - R1508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki
Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy
Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1824 - H1831.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Makino, M. Sugano, S. Otsuka, and T. Hata
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
Hypertension, October 1, 1997; 30(4): 796 - 802.
[Abstract] [Full Text]


Home page
CirculationHome page
E. O. Weinberg, M. A. Lee, M. Weigner, K. Lindpaintner, S. P. Bishop, C. R. Benedict, K. K. L. Ho, P. S. Douglas, E. Chafizadeh, and B. H. Lorell
Angiotensin AT1 Receptor Inhibition : Effects on Hypertrophic Remodeling and ACE Expression in Rats With Pressure-Overload Hypertrophy due to Ascending Aortic Stenosis
Circulation, March 18, 1997; 95(6): 1592 - 1600.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Yamazaki, I. Komuro, Y. Zou, S. Kudoh, I. Shiojima, Y. Hiroi, T. Mizuno, R. Aikawa, H. Takano, and Y. Yazaki
Norepinephrine Induces the raf-1 Kinase/Mitogen-Activated Protein Kinase Cascade Through Both {alpha}1- and ß-Adrenoceptors
Circulation, March 4, 1997; 95(5): 1260 - 1268.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Kudoh, I. Komuro, T. Mizuno, T. Yamazaki, Y. Zou, I. Shiojima, N. Takekoshi, and Y. Yazaki
Angiotensin II Stimulates c-Jun NH2-Terminal Kinase in Cultured Cardiac Myocytes of Neonatal Rats
Circ. Res., January 1, 1997; 80(1): 139 - 146.
[Abstract] [Full Text]


Home page
HypertensionHome page
F. Elijovich, H.-W. Zhao, C. L. Laffer, Y. Du, D. J. DiPette, T. Inagami, and D. H. Wang
Regulation of Growth of the Adrenal Gland in DOC-Salt Hypertension: Role of Angiotensin II Receptor Subtypes
Hypertension, January 1, 1997; 29(1): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zou, I. Komuro, T. Yamazaki, R. Aikawa, S. Kudoh, I. Shiojima, Y. Hiroi, T. Mizuno, and Y. Yazaki
Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes
J. Biol. Chem., December 27, 1996; 271(52): 33592 - 33597.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kobayashi, M. Yano, M. Kohno, M. Obayashi, Y. Hisamatsu, T. Ryoke, T. Ohkusa, K. Yamakawa, and M. Matsuzaki
Influence of Aortic Impedance on the Development of Pressure-Overload Left Ventricular Hypertrophy in Rats
Circulation, December 15, 1996; 94(12): 3362 - 3368.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. M. Touyz, J. Fareh, G. Thibault, and E. L. Schiffrin
Intracellular Ca2+ Modulation by Angiotensin II and Endothelin-1 in Cardiomyocytes and Fibroblasts From Hypertrophied Hearts of Spontaneously Hypertensive Rats
Hypertension, November 1, 1996; 28(5): 797 - 805.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
K. Kijima, H. Matsubara, S. Murasawa, K. Maruyama, Y. Mori, N. Ohkubo, I. Komuro, Y. Yazaki, T. Iwasaka, and M. Inada
Mechanical Stretch Induces Enhanced Expression of Angiotensin II Receptor Subtypes in Neonatal Rat Cardiac Myocytes
Circ. Res., October 1, 1996; 79(4): 887 - 897.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Susic, E. Nunez, E. D. Frohlich, and O. Prakash